Weight Changes in Fecal Microbiota Transplant for Clostridium difficile

BACKGROUND: Fecal microbiota transplant (FMT) for relapsing Clostridium difficile infections (CDI) allows for rapid repopulation of the colonic microbiome and may prevent future relapses. FMT is considered safe, however subsequent impact on weight and metabolism are incompletely understood. Animal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussam, Dina, Drees, Marci, Myerson, Scott, Duffalo, Chad, Mosby, Danielle, Herdman, Christine, Depalma, Fedele, Mcgraw, Patty, Bacon, Alfred E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631535/
http://dx.doi.org/10.1093/ofid/ofx163.957
_version_ 1783269497041321984
author Hussam, Dina
Drees, Marci
Myerson, Scott
Duffalo, Chad
Mosby, Danielle
Herdman, Christine
Depalma, Fedele
Mcgraw, Patty
Bacon, Alfred E
author_facet Hussam, Dina
Drees, Marci
Myerson, Scott
Duffalo, Chad
Mosby, Danielle
Herdman, Christine
Depalma, Fedele
Mcgraw, Patty
Bacon, Alfred E
author_sort Hussam, Dina
collection PubMed
description BACKGROUND: Fecal microbiota transplant (FMT) for relapsing Clostridium difficile infections (CDI) allows for rapid repopulation of the colonic microbiome and may prevent future relapses. FMT is considered safe, however subsequent impact on weight and metabolism are incompletely understood. Animal studies have shown that alterations in microbiota lead to changes in weight; this is also suggested in humans, based on limited anecdotal evidence. This study explores changes in weight associated with FMT. METHODS: We conducted a retrospective observational study of patients who underwent FMT at our 1100-bed community-based academic healthcare system. FMT protocol requires 2 documented CDI relapses and failed vancomycin taper. FMT methods include colonoscopy, EGD and oral capsules. Of note, donor stool (OpenBiome, Boston, Massachusetts) criteria include BMI <30. We conducted chart review for documented provider-measured weights pre- and post- FMT (≤ 1 year), and compared pre-FMT weights to last recorded weight within 1-year period. We also evaluated weights in a subset of patients in the acute (2–6 week post FMT) timeframe. RESULTS: Between Apr 2014- Oct 2016, 41 patients underwent FMT. Of these, 31 (75%) patients had adequate weight data available for review (Table). Overall patients gained an average 2.4%. During the acute phase, 20 patients (65%) had documented weights; of these 50% lost and 50% gained weight, with overall weight loss of 0.7%. CONCLUSION: In this limited population, it appears FMT may predispose to weight gain, which may reflect improved health with CDI cure. However, effects of FMT on patient’s microbiomes must also be considered. As this intervention becomes more widely used we must be increasingly aware of possible metabolic side effects and ensure documentation of weight changes as part of FMT protocols. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631535
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56315352017-11-07 Weight Changes in Fecal Microbiota Transplant for Clostridium difficile Hussam, Dina Drees, Marci Myerson, Scott Duffalo, Chad Mosby, Danielle Herdman, Christine Depalma, Fedele Mcgraw, Patty Bacon, Alfred E Open Forum Infect Dis Abstracts BACKGROUND: Fecal microbiota transplant (FMT) for relapsing Clostridium difficile infections (CDI) allows for rapid repopulation of the colonic microbiome and may prevent future relapses. FMT is considered safe, however subsequent impact on weight and metabolism are incompletely understood. Animal studies have shown that alterations in microbiota lead to changes in weight; this is also suggested in humans, based on limited anecdotal evidence. This study explores changes in weight associated with FMT. METHODS: We conducted a retrospective observational study of patients who underwent FMT at our 1100-bed community-based academic healthcare system. FMT protocol requires 2 documented CDI relapses and failed vancomycin taper. FMT methods include colonoscopy, EGD and oral capsules. Of note, donor stool (OpenBiome, Boston, Massachusetts) criteria include BMI <30. We conducted chart review for documented provider-measured weights pre- and post- FMT (≤ 1 year), and compared pre-FMT weights to last recorded weight within 1-year period. We also evaluated weights in a subset of patients in the acute (2–6 week post FMT) timeframe. RESULTS: Between Apr 2014- Oct 2016, 41 patients underwent FMT. Of these, 31 (75%) patients had adequate weight data available for review (Table). Overall patients gained an average 2.4%. During the acute phase, 20 patients (65%) had documented weights; of these 50% lost and 50% gained weight, with overall weight loss of 0.7%. CONCLUSION: In this limited population, it appears FMT may predispose to weight gain, which may reflect improved health with CDI cure. However, effects of FMT on patient’s microbiomes must also be considered. As this intervention becomes more widely used we must be increasingly aware of possible metabolic side effects and ensure documentation of weight changes as part of FMT protocols. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631535/ http://dx.doi.org/10.1093/ofid/ofx163.957 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hussam, Dina
Drees, Marci
Myerson, Scott
Duffalo, Chad
Mosby, Danielle
Herdman, Christine
Depalma, Fedele
Mcgraw, Patty
Bacon, Alfred E
Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title_full Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title_fullStr Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title_full_unstemmed Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title_short Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
title_sort weight changes in fecal microbiota transplant for clostridium difficile
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631535/
http://dx.doi.org/10.1093/ofid/ofx163.957
work_keys_str_mv AT hussamdina weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT dreesmarci weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT myersonscott weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT duffalochad weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT mosbydanielle weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT herdmanchristine weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT depalmafedele weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT mcgrawpatty weightchangesinfecalmicrobiotatransplantforclostridiumdifficile
AT baconalfrede weightchangesinfecalmicrobiotatransplantforclostridiumdifficile